Ratings Indorama Ventures

Equities

IVL

TH1027010004

End-of-day quote Thailand S.E. Other stock markets 06:00:00 2024-05-12 pm EDT			5-day change	1st Jan Change
24.3 ^THB	+3.40%		+3.85%	-10.83%

May. 10	Indorama Ventures Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 25	Indorama Ventures Public Company Limited Approves Dividend for the Year Ended December 31, 2023, Payable on 23 May 2024	CI

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
According to Refinitiv, the company's ESG score for its industry is good.

Strengths

The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
The company's share price in relation to its net book value makes it look relatively cheap.
Given the positive cash flows generated by its business, the company's valuation level is an asset.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The company has insufficient levels of profitability.
The group shows a rather high level of debt in proportion to its EBITDA.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Commodity Chemicals

	1st Jan change	Capi.	ESG Refinitiv
INDORAMA VENTURES	-10.83%	3.71B	C+
AIR LIQUIDE	+5.66%	105B	A-
SABIC	-2.87%	64.68B	A-
PT CHANDRA ASRI PACIFIC TBK	+53.33%	43.21B	B
WANHUA CHEMICAL GROUP CO., LTD.	+17.94%	39.33B	B
LYONDELLBASELL INDUSTRIES N.V.	+6.56%	32.99B	A-
WESTLAKE CORPORATION	+11.65%	20.09B	B-
NINGXIA BAOFENG ENERGY GROUP CO., LTD.	+14.15%	17.05B	C+
HENGLI PETROCHEMICAL CO.,LTD.	+24.53%	15.96B	B-
RONGSHENG PETROCHEMICAL CO., LTD.	+7.25%	14.69B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes